We are live on ! Find out more
MTIP

Magee Thomson Investment Partners Portfolio holdings

AUM $259M
1-Year Est. Return 34.48%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+34.48%
3 Year Est. Return
+94.32%
5 Year Est. Return
10 Year Est. Return
AUM
$440M
AUM Growth
Cap. Flow
+$432M
Cap. Flow %
98.25%
Top 10 Hldgs %
41.76%
Holding
137
New
137
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$23.3M
2
GILD icon
Gilead Sciences
GILD
+$20.3M
3
SBUX icon
Starbucks
SBUX
+$18.3M
4
MA icon
Mastercard
MA
+$18.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$17.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 24.61%
2 Consumer Discretionary 20.54%
3 Healthcare 14.65%
4 Technology 11.94%
5 Financials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XXIA
76
DELISTED
Ixia
XXIA
$147K 0.03%
+7,965
New +$131K
JAZZ icon
77
Jazz Pharmaceuticals
JAZZ
$16.3B
$141K 0.03%
+2,036
New +$124K
ATRO icon
78
Astronics
ATRO
$3.76B
$131K 0.03%
+8,688
New +$104K
SNTS
79
DELISTED
SANTARUS INC
SNTS
$128K 0.03%
+6,050
New +$122K
AKRX
80
DELISTED
Akorn Inc
AKRX
$116K 0.03%
+8,591
New +$121K
SRDX
81
DELISTED
Surmodics
SRDX
$106K 0.02%
+5,344
New +$134K
DECK icon
82
Deckers Outdoor
DECK
$13.6B
$98K 0.02%
+11,796
New +$107K
SCMP
83
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$78K 0.02%
+11,998
New +$95.2K
MNKD icon
84
MannKind Corp
MNKD
$1.27B
$68K 0.02%
+2,117
New +$56.7K
INSM icon
85
Insmed
INSM
$21.8B
$62K 0.01%
+5,295
New +$54.1K
PCRX icon
86
Pacira BioSciences
PCRX
$986M
$58K 0.01%
+2,016
New +$58.3K
INFI
87
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$23K 0.01%
+1,412
New +$43.7K
AEGR
88
DELISTED
Aegerion Pharmaceuticals
AEGR
$11K ﹤0.01%
+163
New +$8.65K
RPTP
89
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$10K ﹤0.01%
+1,040
New +$7.04K
XONE
90
DELISTED
The ExOne Company
XONE
$9K ﹤0.01%
+150
New +$6.33K
PFPT
91
DELISTED
Proofpoint, Inc.
PFPT
$9K ﹤0.01%
+387
New +$7.52K
BGFV
92
DELISTED
Big 5 Sporting Goods
BGFV
$8K ﹤0.01%
+363
New +$6.8K
IIIN icon
93
Insteel Industries
IIIN
$635M
$8K ﹤0.01%
+482
New +$8.3K
IMOS
94
ChipMOS TECHNOLOGIES
IMOS
$1.8B
$8K ﹤0.01%
+387
New +$7K
ACIC icon
95
American Coastal Insurance
ACIC
$532M
$7K ﹤0.01%
+962
New +$5.92K
ACLS icon
96
Axcelis
ACLS
$4.2B
$7K ﹤0.01%
+1,000
New +$5.81K
APOG icon
97
Apogee Enterprises
APOG
$903M
$7K ﹤0.01%
+280
New +$7.29K
FC icon
98
Franklin Covey
FC
$244M
$7K ﹤0.01%
+498
New +$6.91K
LFCR icon
99
Lifecore Biomedical
LFCR
$164M
$7K ﹤0.01%
+494
New +$6.83K
MDXG icon
100
MiMedx Group
MDXG
$612M
$7K ﹤0.01%
+920
New +$6.43K

Similar funds

Magee Thomson Investment Partners's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Magee Thomson Investment Partners, which disclosed 137 positions worth $440M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Allergan plc: 205,922 shares worth $26M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, followed by Consumer Discretionary and Healthcare.

  • Magee Thomson Investment Partners's largest Q2 2013 buy was Allergan plc: 205,922 shares worth $26M.
  • Magee Thomson Investment Partners's ten largest holdings make up 42% of its $440M portfolio in Q2 2013.
  • Magee Thomson Investment Partners disclosed 137 positions in Q2 2013, its first 13F filing on record.

Based on Magee Thomson Investment Partners's 13F filing for Q2 2013, filed 24 Jul 2013.